Semaglutide is an injectable drug formulated for the treatment of type 2 diabetes, but it’s since become increasingly popular as a weight loss treatment. While the drug—commonly known by brand names ...

Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a once-weekly injection. It’s administered with a tiny needle that punctures ...

Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a once-weekly injection. It's administered with a tiny needle that punctures ...

A new diabetes pill beat oral semaglutide on blood sugar and weight loss, but nearly 10% stopped treatment due to side ...

GLP-1 therapy is titrated upward over several months, and on many telehealth platforms the monthly bill climbs with it, so ...

A systematic review of 1,000 screened records identified only three eligible studies examining administration timing for ...

Now that the shortage of semaglutide injection products has been resolved, the Food and Drug Administration (FDA) will restrict third parties from compounding the drug. Our FDA/Food, Drug & Device and ...

MISSISSAUGA, ON, Dec. 15, 2025 /CNW/ - Novo Nordisk announced today that Health Canada has issued marketing authorization with conditions [Notice of Compliance with Conditions (NOC/c)] for Wegovy® ...

Alexandria, VA - (NewMediaWire) - September 25, 2023 - As the health and wellness industry evolves, cutting-edge treatments like Semaglutide injections for weight loss and personalized IV hydration ...

In the ever-evolving landscape of weight management and diabetes treatment, semaglutide has emerged as a significant player. Originally approved by the FDA for managing type 2 diabetes under Ozempic, ...